News | March 25, 2023
Quantumzyme receives patent for development of green catalyst in India
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
hubergroup’s two newly added medical vans are dedicated to dental and eye care
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
Subscribe To Our Newsletter & Stay Updated
